EGFR and lung cancer: Current strategies to treat cancer is mainly driven by identifying genetic changes (e.g., EGFR, epidermal growth factor mutations in lung cancer), but recent evidence suggests that epigenetic plasticity together with genetic lesions also drives tumor progression [25], [26].